Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Front Immunol ; 13: 1094727, 2022.
Article in English | MEDLINE | ID: mdl-36591287

ABSTRACT

SARS-CoV-2 mRNA vaccines prevent severe COVID-19 by generating immune memory, comprising specific antibodies and memory B and T cells. Although children are at low risk of severe COVID-19, the spreading of highly transmissible variants has led to increasing in COVID-19 cases and hospitalizations also in the youngest, but vaccine coverage remains low. Immunogenicity to mRNA vaccines has not been extensively studied in children 5 to 11 years old. In particular, cellular immunity to the wild-type strain (Wuhan) and the cross-reactive response to the Omicron variant of concern has not been investigated. We assessed the humoral and cellular immune response to the SARS-CoV-2 BNT162b2 vaccine in 27 healthy children. We demonstrated that vaccination induced a potent humoral and cellular immune response in all vaccinees. By using spike-specific memory B cells as a measurable imprint of a previous infection, we found that 50% of the children had signs of a past, undiagnosed infection before vaccination. Children with pre-existent immune memory generated significantly increased levels of specific antibodies, and memory T and B cells, directed against not only the wild type virus but also the omicron variant.


Subject(s)
COVID-19 , Vaccines , Humans , Child , Child, Preschool , BNT162 Vaccine , SARS-CoV-2 , COVID-19/prevention & control , Immunologic Memory , mRNA Vaccines , Antibodies
2.
Autophagy ; 14(1): 22-37, 2018.
Article in English | MEDLINE | ID: mdl-29130391

ABSTRACT

Vici syndrome is a human inherited multi-system disorder caused by recessive mutations in EPG5, encoding the EPG5 protein that mediates the fusion of autophagosomes with lysosomes. Immunodeficiency characterized by lack of memory B cells and increased susceptibility to infection is an integral part of the condition, but the role of EPG5 in the immune system remains unknown. Here we show that EPG5 is indispensable for the transport of the TLR9 ligand CpG to the late endosomal-lysosomal compartment, and for TLR9-initiated signaling, a step essential for the survival of human memory B cells and their ultimate differentiation into plasma cells. Moreover, the predicted structure of EPG5 includes a membrane remodeling domain and a karyopherin-like domain, thus explaining its function as a carrier between separate vesicular compartments. Our findings indicate that EPG5, by controlling nucleic acids intracellular trafficking, links macroautophagy/autophagy to innate and adaptive immunity.


Subject(s)
Adaptive Immunity , Autophagy/immunology , DNA/metabolism , Endosomes/metabolism , Immunity, Innate , Lysosomes/metabolism , Proteins/metabolism , RNA/metabolism , Agenesis of Corpus Callosum/genetics , Agenesis of Corpus Callosum/immunology , Autophagy-Related Proteins , B-Lymphocytes/immunology , Biological Transport , Cataract/genetics , Cataract/immunology , Cell Line , Humans , Lysosomal Membrane Proteins , Mutation , Proteins/genetics , Toll-Like Receptor 9/metabolism , Vesicular Transport Proteins
SELECTION OF CITATIONS
SEARCH DETAIL
...